Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
   
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  Antibodies
  Mutations
  AlzGene
  Research Models
Resources
  Jobs
  Conference Calendar
  Grants
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Expert Opinion
  Ask the Expert
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Genes: AlzGene
 Disclaimer
Back Search Methods Disclaimer Credits

General Disclaimer

The overarching goal of this database is to serve as an unbiased, centralized, publicly available and regularly updated collection of genetic association studies performed on various Alzheimer disease (AD) phenotypes. To ensure the highest degree of objectivity regarding the posted information, only studies published or in press in peer-reviewed journals available in English are considered for inclusion into the database. Abstracts presented at scientific meetings or findings reported in non peer-reviewed publications are not considered for inclusion.

While we have made every possible effort to correctly represent the data of all studies fulfilling the above criteria, we cannot exclude the possibility that some studies are cited incorrectly or are erroneously excluded. However, we are not able to make any warranty, either expressed or implied, with respect to the functioning and accuracy of this database. No responsibility is assumed by the authors and curators.

To report an error in the data or to submit general concerns, comments, and suggestions about the database, please contact us. We encourage authors of original AD association studies either published or in press at a peer-reviewed scientific journal to send us your data.

Genome Screen Overview Disclaimer

Please note that the genome screen overview is only meant to provide a qualitative summary of the currently published full-genome screens in AD. The threshold criteria used for inclusion, as well as the fact that several studies have used overlapping AD populations could lead to a false-positive bias for some regions. Unfortunately, it is impossible to judge which of these "concordant" regions actually harbor genuine AD genes at this time. Furthermore, it cannot be excluded that chromosomes or chromosomal regions that do not appear in this overview actually contain relevant AD susceptibility genes. As soon as a meta-analysis—which should provide a more quantitative and unbiased summary—of these genome screens becomes available, it will replace the current qualitative overview table.

Meta-analyses Disclaimer

Please note that while the meta-analyses presented in this database take into account between-study heterogeneity, they do not consider potential confounding by publication bias, i.e., that the outcome/significance of any particular study directly influences its probability of publication. Thus, the gene-specific summary ORs presented in the meta-analysis section may be biased either upward or downward, depending on the publication probability for the particular gene or polymorphism.

Forum Calendar

Live Discussion: Targeting Tumor Necrosis Factor—A Therapeutic Strategy for AD. Join us for a live discussion led by Yong Shen on 28 May 2008 from 2:00-4:00 p.m. EST.

Forum Discussion: Do Somatic Mutations Generate Toxic Abeta Peptides in Sporadic Alzheimer Disease?
This discussion is led by Vincent Marchesi of Yale University. We invite your comments.

Forum Discussion: Collective Thought at Its Best: Let’s Contemplate the Centennial
Enjoy the offerings of this Centennial Page, and write back with your comments.

Special issue on Alzheimer's disease in Neurological Research
Full Text of "Progenitor Endothelial Cell Involvement in Alzheimer's Disease." By Thomas F. Budinger
Part 1 (.pdf); Part II (.pdf); Table of Contents (.pdf). Presented with permission from Forefront Publishing.


Polls
 
Is AD just the extreme end of the spectrum of normal brain aging?

Yes - we'd all get it if we lived long enough
 16
 
No - it's a pathologic process distinct from normal aging
 57
 
We don't know enough to say one way or the other
 26
 
Responses: 99
 
 
 
 
 
Archived Polls
 
Desperately

Antibodies
Collaborators
Cell Lines
Research Participants
Copyright © 1996-2008 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad